Project

SAKK 15/19 Thoracic radiotherapy plus maintenance Durvalumab after first line Carboplatin and Etoposide plus Durvalumab in extensive-stage disease small cell lung cancer (EDSCLC) A multicenter single arm open label phase il trial

Ongoing - recruitment closed · 2021 until 2027

Früh Martin, Demmer-Steingruber Ruth, Quinter Janine